Urology · Colorado Springs, CO
NPI
1649254905
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1644 Medical Center Pt Ste 200
Colorado Springs, CO, 80907
Phone (719) 634-1994
Groups this clinician bills Medicare through
Medicare paid, 2024
$331K
10,029 services
Medicare patients, 2024
483
Average age 76
Drug cost, 2024
$2.6M
1,900 prescriptions
Company payments, 2025
$765
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jon E Derksen was code J0897 (injection, denosumab, 1 mg), 3,840 times for 31 patients. In total Jon E Derksen billed 10,029 services in 68 codes, and Medicare paid $331K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,840 | 31 | $20.72 | $80K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,218 | 25 | $44.85 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 374 | 253 | $11.78 | $4,404 |
| 99214 Office E&M - Established | Office | 303 | 213 | $82.70 | $25K |
| 81003 Clinical Chemistry | Office | 296 | 232 | $2.19 | $647 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 273 | 19 | $34.39 | $9,388 |
| 99215 Office E&M - Established | Office | 265 | 161 | $136.13 | $36K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 221 | 53 | $49.12 | $11K |
| 51798 Ultrasound - Nonspecific | Office | 183 | 150 | $8.25 | $1,510 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 102 | 44 | $37.67 | $3,843 |
| 76872 Ultrasound - Nonspecific | Facility | 95 | 94 | $24.12 | $2,292 |
| 76942 Ultrasound - Nonspecific | Facility | 90 | 89 | $22.15 | $1,993 |
| 55700 Other Organ Systems | Facility | 90 | 89 | $95.02 | $8,552 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 88 | 22 | $0.33 | $29.29 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 84 | 19 | $34.39 | $2,889 |
By year: 2022 $616K for 10,652 services; 2023 $412K for 12,586 services; 2024 $331K for 10,029 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 296 | 232 | $2.19 | $647 |
| 87798 Infectious Agent Detection by DNA/RNA | 273 | 19 | $34.39 | $9,388 |
| 87481 Infectious Agent Detection by DNA/RNA | 84 | 19 | $34.39 | $2,889 |
| 87653 Infectious Agent Detection by DNA/RNA | 21 | 19 | $34.39 | $722 |
| 87640 Infectious Agent Detection by DNA/RNA | 21 | 19 | $34.39 | $722 |
| 87556 Infectious Agent Detection by DNA/RNA | 21 | 19 | $40.85 | $858 |
| 87651 Infectious Agent Detection by DNA/RNA | 21 | 19 | $34.39 | $722 |
| 87641 Infectious Agent Detection by DNA/RNA | 14 | 13 | $34.39 | $481 |
| 87500 Infectious Agent Detection by DNA/RNA | 14 | 13 | $34.39 | $481 |
Medicare prescription drug claims, 2024
In 2024, the drug Jon E Derksen prescribed most often to Medicare patients was Abiraterone Acetate, with 308 prescriptions and refills. In total Jon E Derksen wrote 1,900 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 308 | 316 | 46 | $426K |
| Tamsulosin Hcl Generic | 281 | 827 | 100 | $5,884 |
| Finasteride Generic | 273 | 814 | 89 | $3,856 |
| Prednisone Generic | 273 | 346 | 47 | $1,528 |
| Orgovyx Relugolix | 116 | 116 | 25 | $301K |
| Dutasteride Generic | 109 | 315 | 46 | $4,935 |
| Myrbetriq Mirabegron | 63 | 164 | 27 | $71K |
| Nubeqa Darolutamide | 62 | 62 | 11 | $810K |
| Ciprofloxacin Hcl Generic | 49 | 49 | 47 | $201 |
| Erleada Apalutamide | 35 | 35 | Under 11 | $505K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 29 | 71 | 11 | $614 |
| Yonsa Abiraterone Acet,submicronized | 24 | 28 | Under 11 | $269K |
| Megestrol Acetate Generic | 24 | 64 | 12 | $2,921 |
| Celecoxib Generic | 23 | 69 | Under 11 | $785 |
| Tadalafil Generic | 22 | 42 | Under 11 | $437 |
Brand drugs: - claims; generic drugs: 1,572 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jon E Derksen $765 ($765 in general payments such as food, travel and fees) from 18 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $150 |
| Abbvie Inc. ABBV | 5 | $88.4 |
| Boston Scientific Corporation BSX | 2 | $69.76 |
| Pfizer Inc. PFE | 3 | $58.1 |
| Astellas Pharma US Inc 4503.T | 2 | $51.93 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.81 |
| Endo USA, Inc. | 2 | $46.97 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $44.29 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $33.39 |
| Accord Healthcare, Inc. | 1 | $26.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.